Free Trial

Oxford Biomedica (OTCMKTS:OXBDF) Trading 18.7% Higher - Should You Buy?

Oxford Biomedica logo with Medical background

Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report)'s stock price rose 18.7% during trading on Thursday . The company traded as high as $4.66 and last traded at $4.66. Approximately 550 shares were traded during trading, a decline of 96% from the average daily volume of 12,757 shares. The stock had previously closed at $3.93.

Oxford Biomedica Price Performance

The company has a debt-to-equity ratio of 1.48, a quick ratio of 2.07 and a current ratio of 2.35. The company's 50 day moving average price is $3.81 and its two-hundred day moving average price is $4.51.

Oxford Biomedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Featured Stories

Should You Invest $1,000 in Oxford BioMedica Right Now?

Before you consider Oxford BioMedica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford BioMedica wasn't on the list.

While Oxford BioMedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines